PX1 Research supplies analytical-grade synthetic bioregulatory peptides, including Bronchogen and Vilon, for automated microplate assays, structural binding studies, and gene expression profiling. All compounds are synthesized under strict quality controls and verified via lot-specific RP-HPLC and mass spectrometry. Every order includes comprehensive documentation to ensure seamless integration into high-throughput screening workflows.
PX1 Research supplies analytical-grade synthetic bioregulatory peptides, including Bronchogen and Vilon, for automated microplate assays, structural binding studies, and gene expression profiling. All compounds are synthesized under strict quality controls and verified via lot-specific RP-HPLC and mass spectrometry. Every order includes comprehensive documentation to ensure seamless integration into high-throughput screening workflows.
To order Bronchogen high-throughput screening compounds for laboratory evaluation, researchers require high-purity, standardized peptide sequences capable of reproducible performance across automated microplate platforms. PX1 Research provides synthetic Bronchogen (Ala-Asp-Glu-Leu) manufactured under stringent ISO 17025 and GMP-compliant conditions, accompanied by lot-specific certificates of analysis (COA), high-performance liquid chromatography (HPLC) chromatograms, and mass spectrometry (MS) characterization.
High-throughput screening (HTS) workflows depend on minimal batch-to-batch variation, low endotoxin levels, and immediate solubility in standard aqueous buffers. PX1 Research supports automated laboratory pipelines by supplying lyophilized Khavinson short-chain peptides that readily dissolve in sterile phosphate-buffered saline (PBS) or molecular biology-grade water, ensuring consistent liquid handling without instrument clogging or signal interference in optical readouts.
Short bioregulatory peptides—pioneered through the research of Dr. Vladimir Khavinson—are low-molecular-weight peptide sequences typically composed of two to four amino acid residues. Preclinical research suggests that these short sequences can penetrate cell membranes, enter nuclear compartments, and interact directly with specific histone proteins and DNA promoter regions.
Unlike large proteins or complex monoclonal antibodies, short peptides like Bronchogen and Vilon exhibit high thermal stability, minimal steric hindrance, and defined binding kinetics. Within the broader framework of research peptides, these ultra-short sequences serve as primary probes for evaluating transcriptional activation, chromatin remodeling, and cellular differentiation pathways in cell-based assays.
Bronchogen is a synthetic tetrapeptide consisting of the amino acid sequence L-alanyl-L-alpha-aspartyl-L-alpha-glutamyl-L-leucine (Ala-Asp-Glu-Leu). In vitro studies indicate that Bronchogen interacts with epithelial cell lines to modulate gene expression related to cellular integrity, surfactant production, and inflammatory cytokine pathways.
When evaluating Bronchogen research protocols, automated screening systems measure parameters such as mRNA upregulation via RT-qPCR, protein expression through fluorescence-based ELISAs, and cell viability assays. The carboxyl and amino side chains within the Ala-Asp-Glu-Leu sequence provide distinct electrostatic properties that facilitate specific binding to double-stranded DNA grooves, modulating promoter accessibility in epithelial cell models.
Researchers seeking to buy Vilon membrane binding assay materials require peptides with confirmed structural identity to assess cellular uptake kinetics. Vilon is a synthetic dipeptide composed of Lysine and Glutamic Acid (Lys-Glu / KE). Preclinical evidence demonstrates that Vilon binds to outer cell membranes before undergoing rapid endocytosis or direct translocation across the lipid bilayer.
If your experimental model aims to buy Vilon membrane binding supplier reagents for fluorescence resonance energy transfer (FRET), surface plasmon resonance (SPR), or radiolabeled binding assays, sequence purity is critical. Impurities or truncated sequences can alter membrane association constants and obscure true receptor-ligand interaction dynamics. Studies utilizing Vilon peptide reagents focus on its capacity to alter chromatin packing states and promote thymic cell proliferation in culture models.
To select the appropriate sequence for high-throughput screening screening panels, researchers frequently evaluate multiple short-chain bioregulators in parallel. Comparing structural profiles allows laboratories to construct comprehensive activity maps across target tissue models.
In cell culture assays, Bronchogen is primarily investigated for respiratory and bronchial epithelial gene regulation, whereas Vilon focuses on immune cell reactivation and chromatin remodeling. Similarly, Chonluten (Glu-Asp-Gly) is evaluated in respiratory tissue culture models alongside Bronchogen to differentiate tripeptide versus tetrapeptide signaling efficiency. Additionally, Epitalon (Ala-Glu-Asp-Gly) serves as a baseline control for telomerase expression assays. Utilizing a standardized suite of Khavinson bioregulatory peptides ensures consistent experimental control across comparative multi-well plates.
Integrating synthetic peptides into high-throughput robotic liquid handling systems demands stringent manufacturing parameters. Unfiltered particulate matter or residual TFA (trifluoroacetic acid) can damage microfluidic channels, disrupt liquid level sensing, and skew absorbance readings.
PX1 Research enforces strict quality assurance criteria for all catalog compounds. Every lot is subjected to rigorous testing prior to distribution:
- **Purity Verification:** Guaranteed ≥98% purity by reverse-phase HPLC (RP-HPLC). - **Mass Accuracy:** Identity confirmed via electrospray ionization mass spectrometry (ESI-MS). - **Endotoxin Control:** Formulated to achieve <0.01 EU/mg, minimizing non-specific inflammatory signaling in cell culture. - **Solvent Residue:** Exhaustive lyophilization eliminates volatile organic solvents and excessive trifluoroacetate salts. - **Domestic Manufacturing:** Synthesized in US-based, GMP-compliant facilities under ISO 17025 laboratory standards. - **Traceability & Logistics:** Full lot traceability with same-day shipping (Monday–Friday) from distribution centers in California and Arizona.
Achieving reproducible z-factor scores in high-throughput screening requires standardized reconstitution procedures. Short hydrophilic peptides like Bronchogen and Vilon exhibit high aqueous solubility, but concentration verification is paramount before dispensing into 384-well or 1536-well microplates.
For optimal storage and stability, lyophilized vials should be reconstituted using sterile, deionized water or phosphate-buffered saline (pH 7.4). Avoid repeated freeze-thaw cycles by aliquoting working stock solutions into single-use low-binding polypropylene tubes. For detailed instructions on handling stock solutions, researchers should consult our comprehensive peptide reconstitution guide.
The primary mechanism under investigation for Khavinson peptides involves direct interactions with cell nuclei. Spectroscopic studies indicate that short peptide sequences insert into the major and minor grooves of double-stranded DNA. This site-specific binding induces localized unwinding of dense heterochromatin into transcriptionally active euchromatin.
In vitro models using fluorescently labeled Bronchogen demonstrate rapid nuclear localization within 30 to 60 minutes of incubation. By destabilizing histone-DNA ionic bonds, Bronchogen enables RNA polymerase complexes to access target genes, including those coding for cytokeratins and anti-inflammatory mediators. Detailed papers discussing these molecular pathways are available through our scientific research portal.
High-throughput screening campaigns require significant volumetric quantities of high-purity peptides to maintain consistency across primary screens, secondary confirmation assays, and IC50 concentration gradients. Discrepancies between peptide lots can invalidate months of automated screening data.
PX1 Research supports core facilities and contract research organizations (CROs) with custom synthesis scales, single-lot reservation programs, and specialized packaging formats (such as 96-tube rack arrays or bulk lyophilized powder). Institutions planning large-scale screening initiatives can establish streamlined procurement routes via our wholesale laboratory account program.
How do I order Bronchogen high-throughput screening materials from PX1 Research?
You can order Bronchogen high-throughput screening compounds directly through the PX1 Research online catalog or by contacting our institutional sales desk for bulk laboratory orders. All orders placed Monday through Friday ship same-day from our facility locations in California and Arizona.
Where can I buy Vilon membrane binding supplier reagents with validated COA?
PX1 Research is a dedicated US supplier providing analytical-grade Vilon for membrane binding and epigenetic research. Every lot includes a public, downloadable Certificate of Analysis featuring RP-HPLC and ESI-MS chromatograms verifying purity above 98%.
What is the recommended reconstitution protocol for Bronchogen in automated screening assays?
Bronchogen should be reconstituted in sterile, micro-filtered water or sterile PBS (pH 7.4). Allow the lyophilized cake to dissolve completely at room temperature without aggressive vortexing, then dilute into working culture media or assay buffer immediately prior to automated dispensing.
What endotoxin thresholds are maintained for PX1 Research bioregulators?
PX1 Research monitors endotoxin levels rigorously, maintaining limits of <0.01 EU/mg on research compounds to ensure zero non-specific macrophage activation or assay interference in cell-based microplate platforms.
How does Bronchogen compare to Vilon in cell culture research models?
Bronchogen (Ala-Asp-Glu-Leu) is primarily evaluated in respiratory and bronchial epithelial cell lines for gene modulation, whereas Vilon (Lys-Glu) is utilized in immune, thymic, and chromatin binding assays to observe nuclear translocation and DNA uncoiling.
What analytical methods are used to verify Vilon membrane binding peptide identity?
Vilon identity and purity are confirmed using High-Performance Liquid Chromatography (RP-HPLC) to assess chemical purity and Electrospray Ionization Mass Spectrometry (ESI-MS) to verify exact molecular weight.
Are PX1 Research compounds intended for human clinical applications?
No. All products sold by PX1 Research, including Bronchogen and Vilon, are supplied strictly for laboratory research use only (RUO) and in vitro experimentation. They are not for human or animal consumption, medical diagnosis, or therapeutic applications.
What storage conditions maintain Bronchogen peptide stability long term?
Lyophilized Bronchogen powder should be stored at -20°C in a dry environment protected from light. Reconstituted aqueous aliquots should be stored at -80°C to prevent degradation and avoid repeated freeze-thaw cycles.
Can PX1 Research supply custom bulk quantities for high-throughput screening libraries?
Yes. Through our wholesale and institutional research program, PX1 Research provides custom lot sizes, multi-gram quantities, and pre-weighed microplate formats tailored for high-throughput screening libraries.
Why is US manufacturing critical for bioregulatory peptide screening research?
US-based manufacturing in GMP-compliant, ISO 17025 accredited facilities guarantees strict adherence to quality specifications, eliminates international customs delays, and ensures consistent chemical synthesis across all assay lots.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.